A study of poor responders for long-term, low-dose macrolide administration for chronic sinusitis

Rhinology

Volumn 47, Issue 1, 2009, Pages 66-71

  Haruna, Shinichi ^a   Shimada, Chieko ^b   Ozawa, Masashi ^b   Fukami, Satoru ^a   Moriyama, Hiroshi ^b  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bronchial asthma; CT images; Eosinophil; Macrolide therapy; Nasal polyp; Polypectomy

Indexed keywords

ANTIINFECTIVE AGENT; CLARITHROMYCIN; ROXITHROMYCIN;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG ADMINISTRATION; DRUG RESISTANCE; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; SINUSITIS; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; CLARITHROMYCIN; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; ROXITHROMYCIN; SINUSITIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT FAILURE; YOUNG ADULT;

EID: 62649159981     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Hashiba M, Baba S. Efficacy of long-term administration of Clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol 1996; 525: 73-78.
2. Cervin A, Kalm O, Sandkuli P, Lindberg S. One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: Clinical outcome and effects on mucociliary parameters and nasal nitric oxide. Otolaryngol Head Neck Surg 2002; 126: 481-489.
3. Ichimura K, Shimazaki Y, Ishibashi T, Higo R. Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis. Auris Nasus Larynx 1996; 23: 48-56.
4. Yamada T, Fujieda S, Mori S, Yamamoto H, Saito H. Macrolide treatment decreased the size of nasal polyps and IL-8 levels in nasal lavage. Am J Rhinol 2000; 14: 143-148.
5. Duguid IG, Evans E, Brown MR, Gilbert P. Effect of biofilm culture upon the susceptibility of staphylococcus epidermidis to tobramycin. J Antimicrob Chemother 1992; 30: 813-810.
6. Cervin A, Wallwork B. Macrolide therapy of chronic rhinosinusitis. Rhinology 2007; 45: 259-267.
7. Iino Y, Sugita K, Toriyama M, Kudo K. Erythromycin therapy for otitis media with effusion in sinobronchial syndrome. Arch Otolaryngol Head Neck Surg 1993; 119: 648-651.
8. Goswami SK, Kivity S, Marom Z. Erythromycin inhibits respiratory glycoconjugates secretion from human airways in vitro. Am Rev Respir Dis 1990; 1: 72-78.
9. Rhee CS, Majima Y, Arima S, Jung HW, Jinn TH, Min YG, Sakakura Y. Effects of clarithromycin on rheological properties of nasal mucus in patients with chronic sinusitis. Ann Oto Rhinol Laryngo 2000; 109: 484-487.
10. Suzuki H, Shimomura A, Ikeda K, Oshima T, Takasaka T. Effects of long-term low-dose macrolide administration on neutrophil recruitment and IL-8 in the nasal discharge of chronic sinusitis patients. Tohoku J Exp Med 1997; 182: 115-124.
11. Kadota J, Sakito O, Kohno S, Abe K, Shirai R, Kawakami K, Iida K, Morikawa T, Kusano S, Hara K. Roxithromycin treatment in patients with chronic lower respiratory tract disease-its clinical efficacy and effect on cytokine. Kansenshougaku Zasshi 1994; 68: 27-33.
12. Nonaka M, Pawankar R, Tomiyama S, Yagi T. A macrolide antibiotic, roxithromycin, inhibits the growth of nasal polyp fibroblasts. Am J Rhinol 1999; 13: 267-272.
13. Wallwork B. Coman W, Mackay-Sim A, Greiff L, Cervin A. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 2006; 116: 189-193.
14. Suzuki H, Ikeda K, Honma R, Gotoh S, Oshima T, Furukawa M, Takasaka T. Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy. ORL J Otorhinolaryngol Relat Spec 2000; 62: 121-127.
15. Gotfried MH. Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest. 2004 125(2 Suppl): 52S-60S; quiz 60s-61S.
16. Melen I, Lindahl L, Andreasson L. Chronic maxillary sinusitis. Acta Otolaryngology (Stockh) 1986; 101: 320-327.
17. Shimada T, Ozawa M, Haruna S, Moriyama H. Staging classification of chronic sinusitis. Otorhinolaryngol Tokyo 1999; 42: 165-171.
18. Moriyama H, Yanagi K, Ohtori N, Fukami M. Evaluation of endoscopic sinus surgery for chronic sinusitis: post-operative erythromycin therapy. Rhinology 1995; 33: 166-170.
19. Lund VJ, Kennedy DW, eds. Quantification for staging sinusitis. The staging and therapy group. Ann Oto Rhinol Laryngo Suppl 1995; 167: 17-21.
20. Appenroth E, Gunkel RA, Schrott-Fisher A. Activated and non-activated eosinophils in patients with chronic rhinosinusitis. Acta Otolaryngol (Stockh) 1998; 118: 240-242.
21. Kennedy DW. Prognostic factors, outcomes and staging in ethmoid sinus surgery. Laryngoscope 1992; 102, suppl 57: 1-18.